Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-01-28

FDA Approved: OLOPATADINE HYDROCHLORIDE — Original Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

FDA approves the original application for olopatadine hydrochloride, a generic antihistamine used to treat allergic conjunctivitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OLOPATADINE HYDROCHLORIDE (olopatadine hydrochloride)

Snippet

ORIG AP for OLOPATADINE HYDROCHLORIDE (OLOPATADINE HYDROCHLORIDE)